MicroSintesis

Canada
Charlottetown, Prince Edward Island, Canada

Company profile

MicroSintesis company profile

MicroSintesis is a new life sciences company focused on creating novel anti-infectives. MicroSintesis has developed a unique technology that uses natural bioactive molecules produced by probiotics to reduce significantly the expression of the virulence genes of multiple pathogenic bacteria. The result is a new way to reduce antibiotic use and create a first line of defense in the fight against antibiotic resistance bacteria.

Business identity

Contact email
[email protected]
Phone number
+1-844-442-1110
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2011-01-01, Year

Headquarters

Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$16.4M
Last funding
Series Unknown / $16.4M / 2019-06-27
Last equity funding
Series Unknown / $16.4M
Investors
1
Lead investors
1
Founders
1

Founders and investors

Founders

Hannah McIver

Lead investors

Northern Private Capital (NPC)

Investors

Northern Private Capital (NPC)